Procarta Biosystems
Procarta Biosystems develops a new class of oligonucleotide-based antimicrobial agents designed to treat serious and life-threatening bacterial infections. The company utilizes a rapid and rational research process to create medicines active against drug-resistant strains with a controllable microbiological spectrum. These products target the global healthcare threat of antimicrobial resistance to improve patient well-being.
Biotech
Healthcare
Pharmaceuticals
Funding summary
- Total raised
- €1.5M
- Funding rounds
- 1
Investors in Procarta Biosystems
Investors on record for Procarta Biosystems. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Procarta Biosystems?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors